Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer

Abstract excerpt

// Ulises D. Orlando 1, * , Ana F. Castillo 1, * , Melina A. Dattilo 1 , Angela R. Solano 1 , Paula M. Maloberti 1 , Ernesto J. Podesta 1 1 Biomedical Research Institute, INBIOMED, Department of Biochemistry, School of Medicine, University of Buenos Aires, CABA, Buenos Aires, Argentina * These authors have contributed equally to this work Correspondence to: Ernesto J. Podesta, e-mail: ernestopodesta@yahoo.com.ar...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Inflammatory mediators and NSAID effects
• Share to Peroxisome Proliferator-Activated Receptors
• Share to PI3K/AKT/mTOR signaling in cancer